India's vaccine market to reach Rs 252 billion valuation by 2025: Jitendra Singh https://ift.tt/t0XuWhb

The world is increasingly realising India's superlative capacities in preventive healthcare and the country is now in the process of developing several vaccines, Singh, the minister of state for science and technology, said during a tour of the London Science Museum. He said recently, the first nasal COVID vaccine was successfully manufactured and added that a vaccine related to the Human Papillomavirus (HPV) has helped in the prevention of cervical cancer.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/6KtLUVS